Accumulating evidence indicates that a proinflammatory microenvironment favors the expansion of leukemic cells including CML [16, 32], and an important role of IL-6 in the progression of CML has also been reported [16, 33]. The gene discussed is IL6; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.